1. Lack of Association between Azithromycin and Death from Cardiovascular Causes
- Author
-
Julia C. Dombrowski, Christine M Khosropour, James B. Kent, Matthew R. Golden, Sean D. Schafer, and Jeffrey D. Capizzi
- Subjects
Adult ,Male ,medicine.medical_specialty ,Gonorrhea ,Azithromycin ,urologic and male genital diseases ,Article ,Young Adult ,Internal medicine ,Medicine ,Humans ,Young adult ,Chlamydia ,business.industry ,General Medicine ,Chlamydia Infections ,bacterial infections and mycoses ,medicine.disease ,female genital diseases and pregnancy complications ,Anti-Bacterial Agents ,Increased risk ,Cardiovascular Diseases ,Immunology ,Female ,business ,medicine.drug - Abstract
In this study, treatment of young adults with gonorrhea, chlamydia, or both with a single dose of azithromycin was not associated with an increased risk of death from cardiovascular causes. This finding is reassuring with regard to the use of azithromycin in such patients.
- Published
- 2014